Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2486226 | Journal of Pharmaceutical Sciences | 2010 | 12 Pages |
Abstract
An improved medium scale synthesis of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP), a selective and potent metabotropic glutamate subtype 5 (mGlu5) antagonist, has allowed thorough characterisation of the crystal structures of the free base and the previously unreported hydrochloride (MTEP.HCl). Hirshfeld surface analysis has revealed that molecules in crystalline MTEP are weakly polar, and aggregate through nonclassical C-Hâ¯N hydrogen bonds. A strong ionic N-H+â¯Clâ hydrogen bond dominates the crystal packing in MTEP.HCl. Despite significant differences in the crystal packing, the molecular structures of MTEP and MTEP.HCl are very similar. The acid dissociation constants for MTEP were investigated using 1H NMR spectroscopy. The second acid dissociation constant (pKa2), associated with the pyridine nitrogen, was determined to be 3.40±0.01, whilst pKa1, associated with the thiazole nitrogen, was estimated to be 0.2. The low pKa values make it unlikely that MTEP is protonated in its biologically active form. © 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:234-245, 2010
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Matthew J. McIldowie, Michael N. Gandy, Brian W. Skelton, Jonathan M. Brotchie, George A. Koutsantonis, Mark A. Spackman, Matthew J. Piggott,